First Time Loading...
S

Second Sight Medical Products Inc
NASDAQ:EYES

Watchlist Manager
Second Sight Medical Products Inc
NASDAQ:EYES
Watchlist
Price: 4.14 USD -5.05%
Updated: May 6, 2024
Section:
 

Wall Street
Price Targets

EYES Price Targets Summary
Second Sight Medical Products Inc

There are no price targets for EYES.
EYES Lowest Forecast
Wall Street Target
Not Available
EYES Average Forecast
Wall Street Target
Not Available
EYES Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Second Sight Medical Products Inc Competitors:
Price Targets
L
085370
Lutronic Corp
10% Downside
ELN
El En SpA
7% Upside
CEVI
CellaVision AB
17% Upside
S
605186
Shanghai General Healthy Information and Technology Co Ltd
29% Upside
L
085370
Lutronic Corp
10% Downside
ELN
El En SpA
7% Upside
CEVI
CellaVision AB
17% Upside
S
605186
Shanghai General Healthy Information and Technology Co Ltd
29% Upside
Z
ZOM
Zomedica Corp
182% Upside
SGHT
Sight Sciences Inc
4% Downside
688580
Nanjing Vishee Medical Technology Co Ltd
59% Upside
COH
Cochlear Ltd
11% Downside

Revenue
Forecast

Revenue Estimate
Second Sight Medical Products Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Second Sight Medical Products Inc

Operating Income forecast
is not available for
Second Sight Medical Products Inc

Net Income
Forecast

Net Income Estimate
Second Sight Medical Products Inc

Net Income forecast
is not available for
Second Sight Medical Products Inc

See Also

Summary
EYES intrinsic value, competitors valuation, and company profile.
DCF Valuation
EYES stock valuation using Discount Cash Flow valuation method.
Relative Valuation
EYES stock valuation using valuation multiples.
Wall Street Estimates
EYES price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
EYES stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is EYES's stock price target?
Not Available

EYES doesn't have any price targets made by Wall Street professionals.

ALPHA SPREAD
Join more than 134,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.